MDxHealth SA Current Ratio 2018-2024 | MDXH
MDxHealth SA Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2024-09-30 | $0.07B | $0.05B | 1.54 |
2024-06-30 | $0.04B | $0.05B | 0.91 |
2024-03-31 | $0.03B | $0.02B | 1.69 |
2023-12-31 | $0.04B | $0.02B | 1.96 |
2023-09-30 | $0.05B | $0.02B | 2.42 |
2023-06-30 | $0.00B | 0.00 | |
2023-03-31 | $0.06B | $0.02B | 3.27 |
2022-12-31 | $0.00B | 0.00 | |
2022-09-30 | $0.00B | 0.00 | |
2022-06-30 | $0.05B | $0.02B | 2.38 |
2022-03-31 | $0.00B | 0.00 | |
2021-12-31 | $0.07B | $0.02B | 4.05 |
2021-06-30 | $0.04B | $0.01B | 3.17 |
2020-12-31 | $0.02B | $0.01B | 1.77 |
2020-06-30 | $0.03B | $0.01B | 3.07 |
2019-12-31 | $0.03B | $0.01B | 2.96 |
2019-06-30 | $0.03B | $0.01B | 4.01 |
2018-12-31 | $0.05B | $0.01B | 4.17 |
2017-12-31 | $0.04B | $0.01B | 3.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.000B | $0.070B |
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $8.263B | 0.00 |
Inspire Medical Systems (INSP) | United States | $5.580B | 174.01 |
Hims & Hers Health (HIMS) | United States | $5.276B | 134.17 |
Enovis (ENOV) | United States | $2.580B | 17.49 |
Privia Health (PRVA) | United States | $2.530B | 210.80 |
IRhythm Technologies (IRTC) | United States | $2.313B | 0.00 |
Azenta (AZTA) | United States | $2.227B | 111.05 |
Omnicell (OMCL) | United States | $2.043B | 66.83 |
Clover Health Investments (CLOV) | United States | $1.684B | 0.00 |
10x Genomics (TXG) | United States | $1.609B | 0.00 |
Schrodinger (SDGR) | United States | $1.484B | 0.00 |
Phreesia (PHR) | United States | $1.098B | 0.00 |
Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
Standard BioTools (LAB) | United States | $0.603B | 0.00 |
Talkspace (TALK) | United States | $0.559B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.518B | 0.00 |
Definitive Healthcare (DH) | United States | $0.491B | 85.00 |
Health Catalyst (HCAT) | United States | $0.466B | 0.00 |
Pulmonx (LUNG) | United States | $0.254B | 0.00 |
TruBridge (TBRG) | United States | $0.239B | 69.61 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
American Well (AMWL) | United States | $0.123B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
HeartBeam (BEAT) | United States | $0.075B | 0.00 |
111 (YI) | China | $0.052B | 0.00 |
CareCloud (CCLD) | United States | $0.046B | 0.00 |
Outset Medical (OM) | United States | $0.040B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
Zepp Health (ZEPP) | China | $0.038B | 0.00 |
Movano (MOVE) | United States | $0.021B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.010B | 0.00 |
MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |